Drugs used in Coagulation Disorders Flashcards

(76 cards)

1
Q

Drugs used in clotting/bleeding disorders fall into two categories

A
  1. drugs used to decrease clotting or dissolve clots already present
  2. drugs used to increase clotting in patients at risk of a bleed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anticoagulants are used for

A
  1. acute MI
  2. A-fib
  3. Ischemic stroke
  4. DVT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

anticoag drugs and thromoboylitic drugs are effective againt

A

arterial and venous thrombi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

antiplatelet drugs are used against

A

arterial thrombi only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List the categories of anticoagulants

A

heparins, direct thrombin inhibitors, direct Xa inhibitor, warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

name the thrombolytics

A

urokinase, TPA derivatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

name the antiplatlet drugs

A

aspirin, glycoprotein IIb/IIIa inh., ADP inihibitors, pde uptake inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

dosage route of heparin

A

parenterally (IV or subQ)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

dosage route of coumadin

A

oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

dosage route of thrombin/X inh

A

parenteral or oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

antidote to heparin

A

protamine

works well on unfract. hep, partially on LMWH and not at all on Fondaparinux

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Advantages of LMWH

A

*more specific for ATIII and not II
greater F
longer duration
lower chance of HIT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

example of a LMWH

A

enoxaparin sodium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

heparin like products are measure

A

by APTT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

APPT used to measure

A

effect of heparin and direct thrombin inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Antithrombin II inactivates

A

thrombin, X, 9, 11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Heparin MOA

A

increases ATIII’s activity by 1000 fold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

GPIIb/IIIa is activated by

A

platelet release of ADP, TXA2, and serotonin–> cause upreg of GP2b3a on platelet surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How does HIT happen

A

more common with unfractionated heparin–> IgG ab to PF4-Heparin complex–> results in marked thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

will APTT measure LMWH

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Can heparin be used in pregnancy

A

yes–> does not cross placenta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Fondaparinux

A

mimics the bioactive pentasaccharide on heparin–> same effects, given sub Q once a day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

onset of heparin

A

instant (minutes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

excretion of heparin

A

renal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
choice anticoag during pregnancy
heparin
26
site of action for heparin
blood
27
site of action for coumadin
liver
28
onset of coumadin
slow--> days 10 mg 5 mg 5 mg--> then recheck INR--> decide what to do from there
29
protein C inhibits
factors 5 and 8
30
cleaved by thrombin
1, 5, 8, 11, 13
31
common uses of heaprin
ACUTE | PE, MI, DVT
32
prolonged use of unfractionated heparin is associated with
osteoporosis
33
inibited by heparin
11, 8, 5, *accoriding to the book
34
inhibited by coumadin
2, 7, 9, 10 c, s
35
Direct thrombin inhibitors | administered parenterally
Lepuridin Desirudin bivalirudin argotroban
36
direct thrombin inhibitors | administered orally
Dabigatran
37
MOA of Lepuridin
bind simulatenously to the acitve site of thrombin and thrombin substrates
38
MOA of Argatroban
binds only the thrombin active site
39
reversal agents for dorect thrombin inhibitors and direct Xa inhibitors
none
40
Direct thrombin inhibitor that can also inhibit platelets
Bivalirudin
41
how do you monitor coumadin
PT--> turn it into INR
42
INR range for someone who needs coumadin
2-3
43
INR range for someone with persistent dvt
2.5-3.5
44
antidote for coumadin toxicity
vitamin K, FFP, prothombin complexes
45
MOAS for coumadin
inhibits Vitamin K epoxide reductase preventing Vit K from being replenished and therefore GAMMA carboxylation cannot occur for factors 2, 7, 9, 10 C or S
46
Direct Xa inhibitors
rivaroxaban | apixaban
47
do Direct Xa or Direct thrombin inhibitors require monitoring
no
48
preferred anticoagulant in pt.s with HIT
direct thrombin inhibitors
49
Rivaroxaban indication
pt.s undergoing hip/knee replacement and prevention of stroke for Afib pt.'s
50
Warfarin in the circulation
99% bound | *anything that causes it to come unbound will have a major impact
51
Warfarin broekn down in the liver by
CYP2C9
52
can coumadin be used in pregnant women
no
53
necrosis due to warfarin toxicity is due to
acute deficiency of factor C
54
inducers of CYP--> causing low coumadin and therefore hypercoaguability
rifampin, phenytoin, and barbituates
55
inhibitors of CYP causing warfarin to be too low--> blled risk
SSRI's, cimetidine
56
explain INR
inr= patients test PT/ standard PT (12-13)
57
high INR=
pt is more anticoagulated than a "normal" person and at a risk for bleed *their pt is long=slow clot
58
low INR=
pt is hypercoagulated and at a risk thrombus | *their pt time is quick=fast clotter)
59
Thrombolytic agents
T-PA (alteplase) | streptokinase (protein made by streptococci)
60
Thrombolytic enzymes MOA's
catalyze the cleavage of plasminogen to plasmin so it can cleave fibrin and free serum fibrinogen--> dissolving and preventing a clot
61
seletivity of TPa
only cleaves plasminogen when bound to fibrin (but selectivity is less than you would hope for)
62
streptokinase MOA
does not cleave plasminogen directly-->forms a complex with plasminogen and causes it to undergo conf. change where it is cleaved rapidly by normal TPA
63
does streptokinase show selectivity for fibrin
no
64
most important indication of thrombolytic agents
as an alternative to percuatenous coronary angioplasty in emergency tx of coronary artery thrombosis with 6 hours * also Stroke if within 3 hours * also severe PE
65
name the antiplasmin drugs
tranexamic acid and aminocaproic acid
66
side effect specific to streptokinase
those with prevoius infection to the bacteria may have ab's specific for the drug--> immune response
67
major adverse event you're concerned with about thrombolytic agents
cerebral hemorrhage and bleeding
68
how does PGI2 (prostacylin) inihibit platelet aggregation
increases cAMP which dereases free calcium levels--> this will inihibit platelet aggregation
69
Antipletelet drugs include
1. aspirin and other NSADS (not tyelenol) 2. GP2b3a inh, abciximab, tirofiban, 3. ADP antagonists (clopidogrel) 4. Phosphodiesterase inh. (dipyramidole)
70
dipyramidole MOA
prolong the platelet inhibiting action of cAMP by inhibiting phosphodesterase (which breaks down cAMP)--> Ca2+ stays low and pletelets dont aggregate * increases cGMP levels--> a vasodilator * inhibit the uptake of Adenosine--> increase plasma concentration of adenosine
71
Drug used to treat vitamin K deffieiency
phytonadione
72
most important agents to treat hemophillia A/B
FFP, and factor 8 (A), 9 (B)
73
increases plasma concentration of vWF
desmopressin and factor 8
74
when do you use desmopressin
hemophilia A or to prepare pt.'s non vW disease for elective surgery
75
antiplasmin agents do what
increas clotting for the prevention of acute bleeding apirsodes in patients with hemophillia and others with high risk of bleeding disorders
76
name he antiplasmin meds
aminocaproic acid and tranexamic acid